肾素-血管紧张素系统相关受体在乳腺癌中的研究进展

doi:10.11904/j.issn.1002-3070.2016.04.014

Abstract

Abstract:

Recent studies had demonstrated that Renin-angiotensin system(RAS)plays an important role not only in the cardiovascular system,but also in the occurrence and development of breast cancer.Associated with RAS receptor,Angiotensin Ⅱ(Ang Ⅱ)and Angiotensin 1-7(Ang1-7)which are the major molecules of the RAS,respectively,promote or inhibit the occurrence and development of tumor.In this review,we summarize the current knowledge of the RAS in breast cancer,and discuss the potential application of RAS related receptors targeted drugs in the clinical treatment of breast cancer.

Key words: Renin-angiotensin system, RAS receptor, Breast cancer

CLC Number:

R737.9

WANG Ting,CHEN Xuesong. Research progresses of Renin-angiotensin system receptors in breast cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(4): 365-369.

References

1 Howell A,Anderson AS,Clarke RB,et al.Risk determination and prevention of breast cancer[J].Breast Cancer Res,2014,16(5):446.
2 Rahib L,Smith BD,Aizenberg R,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States[J].Cancer Res,2014,74(11):2913-2921.
3 Muscella A,Greco S,Elia MG,et al.Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells[J].Endocrinol,2002,173(2):315-23.
4 Clere N,Corre I,Faure S,et al.Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis[J].Int J Cancer,2010,127(10):2279-2291.
5 Naffah-Mazzacoratti MG,Gouveia TL,Simes PS,et al.What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?[J].World J Biol Chem,2014,5(2):130-140.
6 Yu C,Tang W,Wang Y,et al.Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry[J].Cancer Lett,2016,376(2):268-277.
7 Moreno-Muoz D,Haba-Rodríguez JR,Conde F,et al.Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients[J].Eur J Clin Invest,2015,45(12):1325-1332.
8 Luo Y,Tanabe E,Kitayoshi M,et al.Expression of MAS1 in breast cancer[J].Cancer Sci,2015,106(9):1240-1248.
9 Chen X,Meng Q,Zhao Y,et al.Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer[J].Cancer Lett,2013,328(2):318-324.
10 Rodrigues-Ferreira S,Abdelkarim M,Dillenburg-Pilla P,et al.Angiotensin II facilitates breast cancer cell migration and metastasis[J].PLoS One,2012,7(4):e35667.
11 Herr D,Rodewald M,Fraser HM,et al.Potential role of renin-angiotensin-system for tumor angiogenesis in receptor negative breast cancer[J].Gynecol Oncol,2008,109(3):418-425.
12 Arrieta O,Pineda-Olvera B,Guevara-Salazar P,et al.Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis[J].Br J Cancer,2008,99(1):160-166.
13 Zhao Y,Chen X,Cai L,et al.Angiotensin II/angiotensin II type I receptor(AT1R)signaling promotes MCF‐7 breast cancer cells survival via PI3‐kinase/Akt pathway[J].J Cell Physiol,2010,225(1):168-173.
14 Du N,Feng J,Hu LJ,et al.Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling[J].Oncol Rep,2012,27(6):1893-1903.
15 Oh E,Kim JY,Cho Y,et al.Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis[J].Biochim Biophys Acta,2016,1863(6):1071-1081.
16 Arrieta O,Villarreal-Garza C,Vizcaíno G,et al.Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer[J].Tumour Biol,2015,36(7):5627-5634.
17 Fujita M,Hayashi I,Yamashina S,et al.Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth[J].Carcinogenesis,2005,26(2):271-279.
18 Egami K,Murohara T,Shimada T,et al.Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth[J].Clin Invest,2003,112(1):67-75.
19 Imai N,Hashimoto T,Kihara M,et al.Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis[J].Lab Invest,2007,87(2):189-198.
20 De Paepe B,Verstraeten VL,De Potter CR,et al.Increased angiotensin II type-2 receptor density in hyperplasia,DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression[J].Histochem Cell Biol,2002,117(1):13-19.
21 Tahmasebi M,Barker S,Puddefoot JR,et al.Localisation of renin-angiotensin system(RAS)components in breast[J].Br J Cancer,2006,95(1):67-74.
22 Muscella A,Greco S,Elia MG,et al.Angiotensin II stimulation of Na⁺/K⁺ ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells[J].J Endocrinol,2002,173(2):315-323.
23 Molina A,Rodrigues-Ferreira S,Di Tommaso A,et al.ATIP,a novel superfamily of microtubule-associated proteins[J].Med Sci,2011,27(3):244-246.
24 Rodrigues-Ferreira S,Di Tommaso A,Dimitrov A,et al.8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis[J].PLoS One,2009,4(10):e7239.
25 Zuern C,Heimrich J,Kaufmann R,et al.Down-regulation of MTUS1 in human colon tumors[J].Oncol Rep,2010,23(1):183-189.
26 Xiao J,Chen JX,Zhu YP,et al.Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer[J].Oncol Lett,2012,4(1):113-118.
27 Passos-Silva DG,Verano-Braga T,Santos RA.Angiotensin-(1-7):beyond the cardio-renal actions[J].Clin Sci,2013,124(7):443-456.
28 Chochieva AR,Bolieva LZ,Dzhioev FK.New approaches to the drug prophylaxis of mammary tumor:evaluation of the prophylactic effect of lovastatin and captopril in rats with experimental mammary gland tumors[J].Eksp Klin Farmakol,2007,71(1):43-45.
29 Bader M,Santos RA,Unger T,et al.New therapeutic pathways in the RAS[J].J Renin Angiotensin Aldosterone Syst,2012,13(4):505-508.
30 Sipahi I,Debanne SM,Rowland DY,et al.Angiotensin-receptor blockade and risk of cancer:meta-analysis of randomised controlled trials[J].Lancet Oncol,2010,11(7):627-636.
31 Azoulay L,Assimes TL,Yin H,et al.Long-term use of angiotensin receptor blockers and the risk of cancer[J].PLoS One,2012,7(12):e50893.
32 Fryzek JP,Poulsen AH,Lipworth L,et al.A cohort study of antihypertensive medication use and breast cancer among Danish women[J].Breast Cancer Res Treat,2006,97(3):23-236.
33 Srensen GV,Ganz PA,Cole SW,et al.Use of β-blockers,angiotensin-converting enzyme inhibitors,angiotensin II receptor blockers,and risk of breast cancer recurrence:a Danish nationwide prospective cohort study[J].J Clin Oncol,2013,31(18):2265-2272.
34 Cardwell CR,Mc Menamin C,Hicks BM,et al.Drugs affecting the renin-angiotensin system and survival from cancer:a population based study of breast,colorectal and prostate cancer patient cohorts[J].BMC Med,2014,12(1):28.
35 Rice AS,Dworkin RH,McCarthy TD,et al.EMA401,an orally administered highly selective angiotensin II type 2 receptor antagonist,as a novel treatment for postherpetic neuralgia:a randomised,double-blind,placebo-controlled phase 2 clinical trial[J].Lancet,2014,383(9929):1637-1647.
36 McCarthy CA,Widdop RE,Denton KM,et al.Update on the angiotensin AT2 receptor[J].Curr Hypertens Rep,2013,15(1):25-30.
37 Wagenaar GTM,Laghmani EH,Fidder M,et al.Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury[J].Am J Physiol Lung Cell Mol Physiol,2013,305(5):340-351.
38 Petty WJ,Miller AA,McCoy TP,et al.Phase I and pharmacokinetic study of angiotensin-(1-7),an endogenous antiangiogenic hormone[J].Clin Cancer Res,2009,15(23):7398-7404.
39 Rodgers KE,Oliver J.Phase Ⅰ/Ⅱ dose escalation study of angiotensin 1-7[A(1-7)]administered before and after chemotherapy in patients with newly diagnosed breast cancer[J].Cancer Chemother Pharmacol,2006,57(5):559-568.
40 Ferreira AJ,Bader M,Santos RA.Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system:a patent review[J].Expert Opin Ther Pat,2012,22(5):567-574.
41 Gallagher PE,Arter AL,Deng G,et al.Angiotensin-(1-7):a peptide hormone with anti-cancer activity[J].Curr Med Chem,2014,21(21):2417-2423.
42 Diop-Frimpong B,Chauhan VP,Krane S,et al.Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors[J].Proc Natl Acad Sci U S A,2011,108(7):2909-2914.
43 Iwai M,Nakaoka H,Senba I,et al.Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling[J].Hypertension,2012,60(1):137-144.
44 Thakur A,Witteles RM.Cancer therapy-induced left ventricular dysfunction:interventions and prognosis[J].J Card Fail,2014,20(3):155-158.
45 Pham H,Schwartz BM,Delmore JE,et al.Pharmacodynamic stimulation of thrombogenesis by angiotensin(1-7)in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy[J].Cancer Chemother Pharmacol,2013,71(4):965-972.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	LI Shuo,ZHANG Nannan,LI Liangliang,LONG Zhiping,YIN Huihui,ZHAO Yashuang,WANG Fan. Relationship between PDE4C gene methylation in peripheral blood leukocytes,interaction of environmental factors and pathogenesis of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 233-238.
[3]	CHEN Yanbo, KONG Dejia, ZHANG Jinfeng, MA Zhigang. Correlation between CYP2D6 gene polymorphism and tamoxifen metabolism in breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 110-114.
[4]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[5]	MA Zhijie, WANG Fan, ZHAO Yashuang. Analysis of life quality and influencing factors in breast cancer patients with chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 149-154.
[6]	MA Zhingying, SHANG Naijian, CAI Miaotian, SHEN Yang, JIANG Zhiyun. Correlation between HER-2 receptor of progesterone and estrogen receptor-positive breast cancer and mammography imaging & clinicopathological features [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 47-51.
[7]	HE Xu, YE shangmian, DONG dandan, LI Ke. The expression of HLA-G in breast cancer and its significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 410-414.
[8]	LIN Rongjie, YIN Hang, ZHOU Yunfeng. Effect of ON123300 on ER+ human breast cancer MCF-7 cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 193-197.
[9]	LI Lin, LI Zhigao. The relationship between metformin and different molecular subtypes of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 267-270.
[10]	ZHENG Wei, XU Shouping, PANG Da. Expression,prognosis and function of long chain non-coding RNA-Linc00152 in breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 7-13.
[11]	YIN Yulian, ZHANG Weihong, ZHOU Yue, YE Meina, CHEN Hongfeng. Correlation between single nucleotide polymorphisms of ERα gene and bone loss associated with aromatase inhibitors in postmenopausal women with breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 14-18.
[12]	LI Yujiao, SHANG Naijian. Research progress of imaging evaluation of neoadjuvant chemotherapy in breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 63-67.
[13]	CHEN Zhuo, KONG Yiran. Effect of silencing UHRF1 on proliferation and metastasis of breast cancer cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 512-518.
[14]	LI Hongyang, SUN Liang, JIANG Xing, YUAN Guangjun, LIU Yan. Dauricine enhances the sensitivity of 5-fluorouracil in human breast cancer MCF-7 cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 385-389.
[15]	LUO Jianing, HAO Chuncheng, ZHANG Jianxin, LU Jiangyue, GE Xiaofeng. Effect of postoperative adjuvant radiotherapy on prognosis of triple-negative breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 411-416.

Research progresses of Renin-angiotensin system receptors in breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments